Article
Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency.
Clinical rheumatology - 1 Feb 2026
Aktas Berkay, Parlar Kerem, Senturk Burak, Saglam Alperen, Dundar Ata, Uc Ceren, Acar Beste, Ugurlu Serdal
Abstract excerpt
BACKGROUND: Familial Mediterranean fever (FMF) is an autoinflammatory disorder associated with MEFV gene mutations. Recurrent febrile episodes associated with serosal inflammation, arthritis, and characteristic skin findings represent the classic presentation of FMF. Lifelong colchicine treatment is the standard of care. However, the feasibility of colchicine cessation in FMF remains controversial, with limited...
Topics
Join the communities discussing this publication.
